Proposed Data Collections Submitted for Public Comment and Recommendations, 76457-76458 [E5-7862]

Download as PDF 76457 Federal Register / Vol. 70, No. 247 / Tuesday, December 27, 2005 / Notices Number of respondents Respondents Treatment group-initial survey ......................................................................... Treatment group-Second survey ..................................................................... Control group-initial survey .............................................................................. Control group-second survey .......................................................................... Number of responses per respondent 90 90 90 90 1 1 1 1 Average burden per response (in hours) 12/60 15/60 12/60 9/60 Total burden (in hours) 18 22.5 18 13.5 Total .......................................................................................................... Dated: December 16, 2005. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E5–7861 Filed 12–23–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–06–06AN] Proposed Data Collections Submitted for Public Comment and Recommendations bjneal on PROD1PC70 with NOTICES In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–4766 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information VerDate Aug<31>2005 14:54 Dec 23, 2005 Jkt 208001 72 technology. Written comments should be received within 60 days of this notice. Proposed Project Understanding the Determinants of Health Disparities within the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)—New— National Center for Chronic Disease Prevention and Health Promotion (NCDDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The purpose of the project is to better understand the determinants of disparities in screening, follow-up, and diagnosis rates among white, black, and Hispanic patients served by the National Breast and Cervical Cancer Early Detection Program. Specifically, the project will examine what structural and system factors contribute to these disparities. Using key informant interviews with staff of selected NBCCEDPs and with local provider representatives (within selected NBCCEDP locations) who are involved in identifying, scheduling, or securing diagnostic and treatment resources for program clients, the project will answer two research questions: (1) How do NBCCEDP programs with a low percentage of disparities and programs with a high percentage of disparities differ in their completeness of follow-up diagnosis with white, black, and Hispanic women for both breast and cervical cancer, and (2) How do NBCCEDP programs with a low percentage of disparities and programs with a high percentage of disparities differ in their timing between screening and diagnosis with white, black, and Hispanic women for both breast and cervical cancer. In addition, recommendations that may serve to enhance technical assistance efforts to NBCCEDPs and local providers will be developed. PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 A total of 80 phone key informant interviews will be conducted across 8 program sites with 10 interviews being conducted per program. NBCCEDP programs were selected utilizing a systematic process based on (1) Measures of interest (completeness of follow-up diagnosis for both breast and cervical cancer and time between screening and diagnosis for both breast and cervical cancer; (2) racial/ethnic and age segmentation of women (i.e. comparing white vs. black and white vs. Hispanic; breast cancer age range: 18– 64, cervical cancer age range: 50–64); (3) percent of minorities served by the program; and (4) disparate screening, follow-up, and diagnosis rates. NBCCEDP Program Directors of the 8 chosen programs were contacted to obtain the names and contact information for the individuals who will be the key informants within the NBCCEDP programs. The data will be collected via telephone interviews with these informants who include: two highlevel management staff (including the program director) with knowledge of structural and system factors that may contribute to the disparate rates, four mid-level staff within the BCCEDP program whose work involves interactions within the clinics who may have insight on clinical and staff factors that may contribute to the disparate rates, and four local-level staff within the BCCEDP program whose work involves working directly with patients and may have insight on patient factors that may contribute to the disparate screening, follow-up, and diagnosis rates among white, black, and Hispanic patients. Interviews will last approximately forty-five minutes each. There are no costs to respondents except other than their time to participate in the survey. Estimated Annualized Burden Hours E:\FR\FM\27DEN1.SGM 27DEN1 76458 Federal Register / Vol. 70, No. 247 / Tuesday, December 27, 2005 / Notices Number of responses per respondent Number of Respondents Respondents Average burden per response (in hrs.) Total burden (in hours) High-Level Management Staff ......................................................................... Mid-level Staff .................................................................................................. Local-level Staff ............................................................................................... 16 32 32 1 1 1 1.5 1.5 1.5 11 21 21 Total .......................................................................................................... 80 ........................ ........................ 53 Dated: December 19, 2005. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E5–7862 Filed 12–23–05; 8:45 am] use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. BILLING CODE 4163–18–P Proposed Project Aerosol Generation by Cough— NEW—The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–06–06AP] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–4766 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the Background and Brief Description The Federal Occupational Safety and Health Act of 1970, section 501, enables NIOSH to carry out research relevant to the health and safety of workers. NIOSH is conducting a two year study of airborne clouds of particles or droplets called ‘‘aerosols’’. Some diseases like influenza and Severe Acute Respiratory Syndrome (SARS) can be spread when people produce infectious aerosols by coughing or sneezing. Aerosol transmission of infectious diseases is especially important to health-care workers and emergency responders, who face a much greater risk of exposure to these hazards than does the general public. Cough-generated aerosols are of particular concern because coughing is one of the most common symptoms of respiratory infections. However, substantial gaps exist in our understanding about the generation of aerosols during coughing. This lack of information hampers the ability of health scientists to model and predict the generation of infectious aerosols by coughing and to understand whether or not cough-generated aerosols are likely to be an important means of transmission of particular diseases. The purpose of this study is to gain a better understanding of the production of aerosols by coughing. The results of this research will give scientists and health professionals’ greater insight into Number of respondents bjneal on PROD1PC70 with NOTICES Respondents Part 1 participants ............................................................................................ Part 2 participants ............................................................................................ VerDate Aug<31>2005 14:54 Dec 23, 2005 Jkt 208001 PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 the airborne transmission of disease and allow them to better assess the potential effectiveness of preventive measures. The first part of this study will measure the quantity and size distribution of aerosol produced during human coughs. To accomplish this, volunteers will cough into a spirometer, which is a commonly used piston-like medical device that measures the volume of air exhaled by a patient. After the volunteer coughs into the spirometer, the air in the spirometer will be drawn into a commercial aerosol measurement device. These experiments will also provide information on how much cough aerosols vary over time for individuals and how much aerosol generation varies between individuals. The second part of this study will determine how effectively surgical masks and N95 respirators block coughgenerated aerosols. N95 respirators are dust masks that are certified to filter out at least 95% of airborne material during normal breathing. N95 respirators are known to be more effective than surgical masks at filtering out airborne particles during inhalation, but it is not known whether masks or respirators are more effective at blocking cough-generated aerosols. For this work, masks and respirators will be placed in a special holder with a disposable mouthpiece, and human subjects will cough into the mouthpiece and through the mask. The aerosol produced by each subject will be analyzed before and after flowing through the mask. These experiments will determine how effective each mask or respirator is at preventing the release of cough-generated aerosols. Volunteers from part 1 may also participate in part 2 if they wish. There will be no costs to study participants other than their time. Estimates of Annualized Burden Number of responses per respondent 20 120 E:\FR\FM\27DEN1.SGM 5 1 27DEN1 Average burden per response (in hours) 1.5 1.5 Total burden (in hours) 150 180

Agencies

[Federal Register Volume 70, Number 247 (Tuesday, December 27, 2005)]
[Notices]
[Pages 76457-76458]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-7862]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-06-06AN]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-4766 
and send comments to Seleda Perryman, CDC Assistant Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Understanding the Determinants of Health Disparities within the 
National Breast and Cervical Cancer Early Detection Program (NBCCEDP)--
New--National Center for Chronic Disease Prevention and Health 
Promotion (NCDDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The purpose of the project is to better understand the determinants 
of disparities in screening, follow-up, and diagnosis rates among 
white, black, and Hispanic patients served by the National Breast and 
Cervical Cancer Early Detection Program. Specifically, the project will 
examine what structural and system factors contribute to these 
disparities. Using key informant interviews with staff of selected 
NBCCEDPs and with local provider representatives (within selected 
NBCCEDP locations) who are involved in identifying, scheduling, or 
securing diagnostic and treatment resources for program clients, the 
project will answer two research questions: (1) How do NBCCEDP programs 
with a low percentage of disparities and programs with a high 
percentage of disparities differ in their completeness of follow-up 
diagnosis with white, black, and Hispanic women for both breast and 
cervical cancer, and (2) How do NBCCEDP programs with a low percentage 
of disparities and programs with a high percentage of disparities 
differ in their timing between screening and diagnosis with white, 
black, and Hispanic women for both breast and cervical cancer. In 
addition, recommendations that may serve to enhance technical 
assistance efforts to NBCCEDPs and local providers will be developed.
    A total of 80 phone key informant interviews will be conducted 
across 8 program sites with 10 interviews being conducted per program. 
NBCCEDP programs were selected utilizing a systematic process based on 
(1) Measures of interest (completeness of follow-up diagnosis for both 
breast and cervical cancer and time between screening and diagnosis for 
both breast and cervical cancer; (2) racial/ethnic and age segmentation 
of women (i.e. comparing white vs. black and white vs. Hispanic; breast 
cancer age range: 18-64, cervical cancer age range: 50-64); (3) percent 
of minorities served by the program; and (4) disparate screening, 
follow-up, and diagnosis rates.
    NBCCEDP Program Directors of the 8 chosen programs were contacted 
to obtain the names and contact information for the individuals who 
will be the key informants within the NBCCEDP programs. The data will 
be collected via telephone interviews with these informants who 
include: two high-level management staff (including the program 
director) with knowledge of structural and system factors that may 
contribute to the disparate rates, four mid-level staff within the 
BCCEDP program whose work involves interactions within the clinics who 
may have insight on clinical and staff factors that may contribute to 
the disparate rates, and four local-level staff within the BCCEDP 
program whose work involves working directly with patients and may have 
insight on patient factors that may contribute to the disparate 
screening, follow-up, and diagnosis rates among white, black, and 
Hispanic patients. Interviews will last approximately forty-five 
minutes each.
    There are no costs to respondents except other than their time to 
participate in the survey.

Estimated Annualized Burden Hours

[[Page 76458]]



----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
                   Respondents                      Respondents    responses per   response (in     (in hours)
                                                                    respondent         hrs.)
----------------------------------------------------------------------------------------------------------------
High-Level Management Staff.....................              16               1             1.5              11
Mid-level Staff.................................              32               1             1.5              21
Local-level Staff...............................              32               1             1.5              21
                                                 -----------------
    Total.......................................              80  ..............  ..............              53
----------------------------------------------------------------------------------------------------------------


    Dated: December 19, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E5-7862 Filed 12-23-05; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.